ArticlePharmaceutical statistics

The Impact of Enrollment Strategies on the Performance of Time-To-Event Dose-Escalation Designs for Phase I Drug Combination Oncology Trials.

Xiaowen Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.